Type B natriuretic peptide stability in frozen plasma.
Daves M, Cemin R
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to investigate the effects of freezing and storage for 30 d, freeze thaw cycling (0, 2, 5, or 10 cycles) and cardiovascular disease on the stability of BNP in plasma specimens without the addition of protease inhibitors.
Summary of Findings
BNP in fresh specimens from 29 healthy individuals ranged from 18-133 ng/L with an average of 57 ng/L. After freezing the specimen and storing it for 30 days at -20 degrees C, no significant change in the mean BNP level for normal specimens was observed. In contrast, the measured BNP in 38 specimens from individuals with cardiovascular disease decreased from an average of 1183 ng/L in fresh specimens to 1108 ng/L (p<0.0001) in specimens frozen for 30 days. Freeze-thaw cycling had no significant effect on BNP levels in three normal specimens, but did result in a progressive decline in 11 specimens from individuals with cardiovascular disease (p=0.04). The authors conclude that at normal physiological levels, BNP is stable through freezing and storage of at least 30 days, and through at least 10 freeze thaw cycles, but at pathological levels, BNP levels decrease over time and with freezing.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
FrozenNone (Fresh)Diagnoses
Cardiovascular DiseaseNormalPlatforms
ProteinELISAPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Cardiovascular diseaseNormalBiospecimen Preservation Type of fixation/preservation FrozenNone (fresh)Storage Freeze/thaw cycling 0 cycles10 cycles2 cycles5 cyclesStorage Storage duration 0 d30 d